FDA Inspection 1292060 — Novo Nordisk US Bio Production Inc.
The FDA completed an inspection of Novo Nordisk US Bio Production Inc. on December 9, 2025 in West Lebanon, NH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 9, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- West Lebanon, NH (United States)